cathepsin k inhibitor Latest Research Papers

Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro

Molecular Biology Reports ◽

10.1007/s11033-020-05951-0 ◽

2020 ◽

Author(s):

Yaongamphi Vashum ◽

Riya Premsingh ◽

Amuthavalli Kottaiswamy ◽

Mathangi Soma ◽

Abirami Padmanaban ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Cathepsin K ◽

Inhibitory Effect ◽

Human Breast Cancer Cells ◽

Human Breast ◽

Cathepsin K Inhibitor

Download Full-text

A phase 1 pooled PK/PD analysis of bone resorption biomarkers for odanacatib, a Cathepsin K inhibitor

Journal of Pharmacokinetics and Pharmacodynamics ◽

10.1007/s10928-020-09699-9 ◽

2020 ◽

Vol 47 (5) ◽

pp. 473-484

Author(s):

Stefan Zajic ◽

S. Aubrey Stoch ◽

Jacqueline B. McCrea ◽

Rose Witter ◽

Ghassan N. Fayad ◽

...

Keyword(s):

Bone Resorption ◽

Phase 1 ◽

Cathepsin K ◽

Cathepsin K Inhibitor

Download Full-text

Role of Cathepsin K Inhibitor & Atorvastatin in Protection Against Atherosclerosis in High Fat Diet-Fed Rats

Biomedical Journal of Scientific & Technical Research ◽

10.26717/bjstr.2020.28.004585 ◽

2020 ◽

Vol 28 (1) ◽

Author(s):

Nisreen Mnasour Aboelmaaty Omar

Keyword(s):

High Fat Diet ◽

Cathepsin K ◽

High Fat ◽

Cathepsin K Inhibitor

Download Full-text

Faculty Opinions recommendation of Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized, Placebo-Controlled Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737143597.793573698 ◽

2020 ◽

Author(s):

Susanne Grässel

Keyword(s):

Cathepsin K ◽

Controlled Study ◽

Cathepsin K Inhibitor ◽

Disease Modifying

Download Full-text

Faculty Opinions recommendation of The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732824430.793573697 ◽

2020 ◽

Author(s):

Susanne Grässel

Keyword(s):

Animal Models ◽

Experimental Animal ◽

Cathepsin K ◽

Experimental Animal Models ◽

Cathepsin K Inhibitor ◽

Joint Pathology

Download Full-text

Population Pharmacokinetic Analysis of the Cathepsin K Inhibitor Odanacatib: Insights Into Intrinsic and Extrinsic Factor Effects on Exposure in Postmenopausal and Elderly Women

The Journal of Clinical Pharmacology ◽

10.1002/jcph.1606 ◽

2020 ◽

Vol 60 (8) ◽

pp. 1107-1123

Author(s):

David Jaworowicz ◽

Sébastien Bihorel ◽

Stefan Zajic ◽

S. Aubrey Stoch ◽

Rebecca Humphrey ◽

...

Keyword(s):

Elderly Women ◽

Cathepsin K ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Extrinsic Factor ◽

Cathepsin K Inhibitor

Download Full-text

Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235)

International Journal of Pharmaceutics ◽

10.1016/j.ijpharm.2019.118772 ◽

2020 ◽

Vol 573 ◽

pp. 118772 ◽

Cited By ~ 6

Author(s):

Voradanu Visetvichaporn ◽

Kyung-Hee Kim ◽

Kyungjin Jung ◽

Yun-Seok Cho ◽

Dae-Duk Kim

Keyword(s):

Drug Delivery ◽

Drug Delivery System ◽

Delivery System ◽

Oral Bioavailability ◽

Cathepsin K ◽

Mixture Design ◽

Cathepsin K Inhibitor

Download Full-text

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis

Annals of Internal Medicine ◽

10.7326/m19-0675 ◽

2019 ◽

Vol 172 (2) ◽

pp. 86 ◽

Cited By ~ 7

Author(s):

Philip G. Conaghan ◽

Michael A. Bowes ◽

Sarah R. Kingsbury ◽

Alan Brett ◽

Gwenael Guillard ◽

...

Keyword(s):

Cathepsin K ◽

Cathepsin K Inhibitor ◽

Disease Modifying

Download Full-text

Safety and efficacy of six months' open label extension post-RCT using the novel cathepsin K inhibitor MIV-711 in patients with knee osteoarthritis

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2019.02.564 ◽

2019 ◽

Vol 27 ◽

pp. S501-S502

Author(s):

P.G. Conaghan ◽

M.A. Bowes ◽

S.R. Kingsbury ◽

A. Brett ◽

G. Guillard ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Cathepsin K ◽

The Novel ◽

Open Label ◽

Safety And Efficacy ◽

Cathepsin K Inhibitor ◽

Open Label Extension

Download Full-text

Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13869 ◽

2019 ◽

Vol 85 (6) ◽

pp. 1072-1083 ◽

Cited By ~ 11

Author(s):

Julie A. Stone ◽

Jacqueline B. McCrea ◽

Rose Witter ◽

Stefan Zajic ◽

S. Aubrey Stoch

Keyword(s):

Cathepsin K ◽

Cathepsin K Inhibitor ◽

Translational Pharmacology

Download Full-text

cathepsin k inhibitor
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro

A phase 1 pooled PK/PD analysis of bone resorption biomarkers for odanacatib, a Cathepsin K inhibitor

Role of Cathepsin K Inhibitor & Atorvastatin in Protection Against Atherosclerosis in High Fat Diet-Fed Rats

Faculty Opinions recommendation of Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized, Placebo-Controlled Study.

Faculty Opinions recommendation of The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis.

Population Pharmacokinetic Analysis of the Cathepsin K Inhibitor Odanacatib: Insights Into Intrinsic and Extrinsic Factor Effects on Exposure in Postmenopausal and Elderly Women

Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235)

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis

Safety and efficacy of six months' open label extension post-RCT using the novel cathepsin K inhibitor MIV-711 in patients with knee osteoarthritis

Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis

Export Citation Format

cathepsin k inhibitorRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro

A phase 1 pooled PK/PD analysis of bone resorption biomarkers for odanacatib, a Cathepsin K inhibitor

Role of Cathepsin K Inhibitor & Atorvastatin in Protection Against Atherosclerosis in High Fat Diet-Fed Rats

Faculty Opinions recommendation of Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized, Placebo-Controlled Study.

Faculty Opinions recommendation of The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis.

Population Pharmacokinetic Analysis of the Cathepsin K Inhibitor Odanacatib: Insights Into Intrinsic and Extrinsic Factor Effects on Exposure in Postmenopausal and Elderly Women

Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235)

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis

Safety and efficacy of six months' open label extension post-RCT using the novel cathepsin K inhibitor MIV-711 in patients with knee osteoarthritis

Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis

cathepsin k inhibitor
Recently Published Documents